MONTREAL, July 2, 2019 /CNW Telbec/ - Mondias Naturals
Inc. ("Mondias" or the "Company") (TSXV: NHP) is pleased to
announce that it has retained the services of Relations Publiques
Paradox Inc. ("Paradox") to provide investor relations services for
the Company, effective July 1, 2019.
Paradox is a Montreal-based
investor relations consultancy firm that has been in business for
20 years. Paradox has represented a number of public companies
through its extensive network and experience in the capital
markets.
Paradox will increase visibility toward the financial community
by direct introduction, marketing strategies and road shows to the
investment community and handle incoming calls from shareholders
and potential investors. Paradox's extensive experience and large
network provides a full-service approach to investor relations and
will provide creative, effective results-driven investor relations
programs for Mondias.
The agreement is for a term of 24 months. Paradox will be paid
$7,500 per month and will receive
stock options exercisable into 450,000 common shares of the Company
for a period of two years at a price of $0.25 per common share. The options will vest in
four equal tranches in each quarter following the date hereof.
The agreement is subject to the approval of the TSX Venture
Exchange.
About Mondias Natural Products Inc.
Mondias
specializes in the commercialization and development of
evidence-based botanical products for the health-care,
bio-agriculture and organic markets. The company sells both oral
and topical botanical agents to help manage unmet medical needs
through its Holizen Laboratories division. Mondias is also
developing botanical-based specialty fertilizers for use on
household plants, lawns and golf courses and in urban gardens,
nurseries and greenhouses, in collaboration with McGill's Faculty
of Agricultural and Environmental Sciences.
For more information, visit: www.mondias.ca
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-looking statements
Some statements in this
release may contain forward-looking information. All statements,
other than of historical fact, that address activities, events or
developments that the Company believes, expects or anticipates will
or may occur in the future (including, without limitation,
statements regarding potential acquisitions and financings) are
forward-looking statements. Forward-looking statements are
generally identifiable by use of the words "may", "will", "should",
"continue", "expect", "anticipate", "estimate", "believe",
"intend", "plan" or "project" or the negative of these words or
other variations on these words or comparable terminology.
Forward-looking statements are subject to a number of risks and
uncertainties, many of which are beyond the Company's ability to
control or predict, that may cause the actual results of the
Company to differ materially from those discussed in the
forward-looking statements. Factors that could cause actual results
or events to differ materially from current expectations include
the Company's inability to obtain sufficient financing to execute
its business plan; competition; regulation; anticipated and
unanticipated costs and delays; the success of the Company's
research and development strategies; the ability to obtain orphan
drug status; the applicability of the discoveries made; the
successful and timely completion and uncertainties related to the
regulatory approval process; the timing of clinical trials; the
timing and outcomes of regulatory or intellectual property
decisions; and other risks disclosed in the Company's public
disclosure record on file with the relevant securities regulatory
authorities. Although the Company has attempted to identify
important factors that could cause actual results or events to
differ materially from those described in forward-looking
statements, there may be other factors that cause results or events
not to be as anticipated, estimated or intended. Readers should not
place undue reliance on forward-looking statements. The
forward-looking statements in this news release are made as of the
date of this news release, and the Company does not undertake any
obligation to publicly update them to reflect new information or
subsequent events or otherwise unless required by applicable
securities legislation.
SOURCE Mondias Natural Products Inc.